CAD1.30
5.80% today
Toronto, Apr 04, 10:00 pm CET
ISIN
CA1380351009
Symbol
WEED

Canopy Growth Corporation Stock price

CAD1.30
-0.49 27.37% 1M
-4.70 78.33% 6M
-2.64 67.01% YTD
-11.90 90.15% 1Y
-96.00 98.66% 3Y
-201.30 99.36% 5Y
-19.10 93.63% 10Y
Toronto, Closing price Fri, Apr 04 2025
-0.08 5.80%
ISIN
CA1380351009
Symbol
WEED

Key metrics

Market capitalization CAD213.67m
Enterprise Value CAD517.89m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.87
P/S ratio (TTM) P/S ratio 0.77
P/B ratio (TTM) P/B ratio 0.30
Revenue growth (TTM) Revenue growth -16.27%
Revenue (TTM) Revenue CAD276.75m
EBIT (operating result TTM) EBIT CAD-95.79m
Free Cash Flow (TTM) Free Cash Flow CAD-162.63m
Cash position CAD185.45m
EPS (TTM) EPS CAD-5.22
P/E forward negative
P/S forward 0.77
EV/Sales forward 1.86
Short interest 2.52%
Show more

Is Canopy Growth Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Canopy Growth Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Canopy Growth Corporation forecast:

1x Buy
10%
5x Hold
50%
4x Sell
40%

Analyst Opinions

10 Analysts have issued a Canopy Growth Corporation forecast:

Buy
10%
Hold
50%
Sell
40%

Financial data from Canopy Growth Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
277 277
16% 16%
100%
- Direct Costs 218 218
32% 32%
79%
59 59
399% 399%
21%
- Selling and Administrative Expenses 112 112
43% 43%
40%
- Research and Development Expense - -
-
-
-53 -53
72% 72%
-19%
- Depreciation and Amortization 43 43
33% 33%
16%
EBIT (Operating Income) EBIT -96 -96
63% 63%
-35%
Net Profit -470 -470
63% 63%
-170%

In millions CAD.

Don't miss a Thing! We will send you all news about Canopy Growth Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Head office Canada
CEO Luc Mongeau
Employees 1,029
Founded 2009
Website www.canopygrowth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today